Q3 2018

Filed Jan 17, 2019 · 10-Q · 17 days after period end · 0001740797-19-000005

Q3 2018 · 10-Q

Revenue—

Net Income

-$19.01K

no prior Q3 2017 on file

EPS Diluted

$0.00

no prior Q3 2017 on file

Gross Profit$0—

Operating Cash Flowderived-$8,484—

Same quarter

no prior Q3 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2018 · filed Jan 17, 2019 · 17 d after period end

Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR